Do We Initiate Chemotherapy at an Early Stage of Hormone-Sensitive Metastatic Prostate Cancer?

被引:0
|
作者
Nayir, Erdinc [1 ]
Keskin, Ozge [2 ]
机构
[1] Kahramanmaras Necip Fazil City Hosp, Dept Med Oncol, Kahramanmaras, Turkey
[2] Aydin Ataturk State Hosp, Dept Med Oncol, Aydin, Turkey
来源
关键词
D O I
10.5505/tjo.2016.1478
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:160 / 161
页数:2
相关论文
共 50 条
  • [1] Role of systemic chemotherapy in metastatic hormone-sensitive prostate cancer
    Shenoy, Niraj
    Kohli, Manish
    INDIAN JOURNAL OF UROLOGY, 2016, 32 (04) : 257 - 261
  • [2] Metastatic hormone-sensitive prostate cancer
    Gravis, Gwenaelle
    Salem, Naji
    Walz, Jochen
    BULLETIN DU CANCER, 2015, 102 (01) : 57 - 64
  • [3] Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
    Wala, Jeremiah
    Nguyen, Paul
    Pomerantz, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (20) : 3584 - +
  • [4] Rezvilutamide for metastatic hormone-sensitive prostate cancer
    Ye, Dingwei
    Gu, Weijie
    Li, Junliang
    LANCET ONCOLOGY, 2022, 23 (11): : E491 - E491
  • [5] Treatment of metastatic hormone-sensitive prostate cancer
    Rane, Jayant K.
    Chowdhury, Amani
    Kinnaird, William
    Marks, Gillian
    Davda, Reena
    TRENDS IN UROLOGY & MENS HEALTH, 2021, 12 (06) : 7 - 10
  • [6] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Bernard, Brandon
    Sweeney, Christopher J.
    CURRENT UROLOGY REPORTS, 2015, 16 (03)
  • [7] Docetaxel for hormone-sensitive metastatic prostate cancer
    Baker, Holly
    LANCET ONCOLOGY, 2015, 16 (09): : E432 - E432
  • [8] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Brandon Bernard
    Christopher J. Sweeney
    Current Urology Reports, 2015, 16
  • [9] Management of Hormone-Sensitive Metastatic Prostate Cancer
    Agarwal, Neeraj
    Hussain, Maha
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1221 - +
  • [10] Update on Metastatic Hormone-Sensitive Prostate Cancer
    Chi, Kim N.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 277 - 280